EURICAN DAPPI-LMULTI LYOPHILISATE AND SUSPENSION FOR SUSPENSION FOR INJECTION
EURICAN DAPPI-LMULTI LYOPHILISATE AND SUSPENSION FOR SUSPENSION FOR INJECTION
Nije ovlašteno
- Canine adenovirus 2, strain DK13, Live
- Canine parainfluenza virus, strain CGF 2004/75, Live
- Canine distemper virus, strain BA5, Live
- Canine parvovirus, strain CAG2, Live
- Leptospira interrogans, serogroup Grippotyphosa, serovar Grippotyphosa, strain Grippo Mal 1540, Inactivated
- Leptospira interrogans, serogroup Icterohaemorrhagiae, serovar Icterohaemorrhagiae, strain 16069, Inactivated
- Leptospira interrogans, serogroup Canicola, serovar Canicola, strain 16070, Inactivated
Identifikacija proizvoda
Naziv VMP-a:
EURICAN DAPPI-LMULTI LYOPHILISATE AND SUSPENSION FOR SUSPENSION FOR INJECTION
Eurican DHPPi2-L3 - Lyofilisat og væske til injeksjonsvæske, suspensjon
Način primjene:
-
Supkutano
Pojedinosti o proizvodu
Djelatna tvar i jačina:
-
Dostupno samo u English316.23tissue culture infective dose 501.00Dose
-
Dostupno samo u English50118.70tissue culture infective dose 501.00Dose
-
Dostupno samo u English10000.00tissue culture infective dose 501.00Dose
-
Dostupno samo u English79432.80tissue culture infective dose 501.00Dose
-
Dostupno samo u English1.00Hamster protective Dose 80 % (Ph. Eur. Monograph)1.00Dose
-
Dostupno samo u English1.00Hamster protective Dose 80 % (Ph. Eur. Monograph)1.00Dose
-
Dostupno samo u English1.00Hamster protective Dose 80 % (Ph. Eur. Monograph)1.00Dose
Farmaceutski oblik:
-
Liofilizat i suspenzija za suspenziju za injekciju
Withdrawal period by route of administration:
-
Supkutano
- Dog
Kod anatomsko-terapijsko-kemijske klasifikacije (ATKvet kȏd):
- QI07AI02
Status odobrenja:
-
Isteklo
Dodatne informacije
Entitlement type:
-
Marketing Authorisation
Nositelj odobrenja za stavljanje u promet:
- Boehringer Ingelheim Animal Health Denmark A/S
Marketing authorisation date:
Mjesta proizvodnje za izdavanje serije:
- Boehringer Ingelheim Animal Health France
Odgovorno tijelo:
- Norwegian Medicines Agency
Broj autorizacije:
- 14-10414
Datum promjene statusa odobrenja:
Broj postupka:
- FR/V/0286/001
To consult adverse reactions on veterinary medicinal products please go to www.adrreports.eu/vet
Koliko je bila korisna ova stranica?: